Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Strategy in Fight against Cancer

Published: Monday, September 22, 2008
Last Updated: Monday, September 22, 2008
Bookmark and Share
Scientists have identified a new strategy in the fight against cancer, having found a mechanism for switching off a chemical signal that is intimately linked to progression of the disease.

Scientists have identified a new strategy in the fight against cancer, having found a mechanism for switching off a chemical signal that is intimately linked to progression of the disease.

Dr Hilary Ashe and her team at the Universities of Manchester, Dundee and Harvard hope their work will, in the future, help develop a therapy to slow the onset of cancer, working at a molecular level instead of attacking the cells with harsh radiotherapy or chemotherapy.

Their Wellcome Trust-funded study, published in Genes & Development, has worked out the mechanism which controls how long a protein with a key role in cancer remains in the nucleus where it carries out its important function.

Tumour suppressor proteins have essential roles in reducing the risk of cancers in different tissues. One of these tumour suppressors is a protein called Medea which acts in the nucleus of normal cells to regulate hundreds of genes necessary for proper cell development.

People predisposed to certain cancer types have greatly reduced amounts of Medea in the nucleus. As a result, the genes which Medea would regulate are not controlled properly leading to the development of cancers. Reduced Medea activity is associated with 90% of pancreatic cancers, 60% of gastric cancers and 30% of breast, prostate and cervical cancers.

Dr Ashe explained: “We have worked out the mechanism by which Medea is moved from the nucleus to the cytoplasm in normal cells. This will be important for cancer cells where there is only a tiny amount of Medea that is only in the nucleus for a short time. One way to fix that is to keep it in the nucleus longer. We now know what directs the protein out of the nucleus so if we stop that, it will compensate for the reduced amount of protein.

“By doing this in early stage cancerous cells, we will increase the chances that cells grow properly and thus greatly reduce the development of cancer.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Early Detection of Lung Cancer
The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease.
Tuesday, August 11, 2015
Molecular Clues to Serious Illnesses to be Explored
The University of Manchester is to lead a new £2.9 million molecular pathology research project to improve diagnosis and treatment of non-cancerous diseases within the NHS.
Friday, July 31, 2015
Molecular Clues to Serious Illnesses to be Explored
The University of Manchester is to lead a new £2.9 million molecular pathology research project to improve diagnosis and treatment of non-cancerous diseases within the NHS.
Tuesday, July 28, 2015
Mould Unlocks New Route to Biofuels
Scientists at The University of Manchester have made an important discovery that forms the basis for the development of new applications in biofuels and the sustainable manufacturing of chemicals.
Monday, July 06, 2015
Gene Variants Show Potential In Predicting Rheumatoid Arthritis Disease Outcomes
Arthritis Research UK-funded scientists at The University of Manchester have identified a new way in which genotyping can be used to predict disease outcomes among sufferers of rheumatoid arthritis.
Thursday, April 30, 2015
Potential For Prediction Of Progression For Early Form Of Breast Cancer
Scientists in Manchester have identified a way to potentially predict which patients with an early form of breast cancer will experience disease progression.
Friday, April 17, 2015
Surprising Finding In Stroke Research
Scientists at The University of Manchester have made an important new discovery about the brain’s immune system that could lead to potential new treatments for stroke and other related conditions.
Wednesday, March 18, 2015
Current Detection of Gene Mutations Misses People At High Risk Of Cancer
Research on the BRCA gene mutation in the Jewish population shows that the current process of identifying people misses half the people who have the mutation and are at risk of developing cancer.
Tuesday, December 02, 2014
‘Liquid Biopsy’ Offers New Way to Track Lung Cancer
Scientists have shown how a lung cancer patient’s blood sample could be used to monitor and predict their response to treatment.
Wednesday, June 04, 2014
New Insight into Drug Resistance in Metastatic Melanoma
A study by scientists in Manchester has shown how melanoma drugs can cause the cancer to progress once a patient has stopped responding to treatment.
Wednesday, June 04, 2014
Health Risks from Arsenic in Rice Exposed
High levels of arsenic in rice have been shown to be associated with elevated genetic damage in humans, a new study has found.
Wednesday, July 24, 2013
Study Maps Human Metabolism in Health and Disease
Scientists have produced an instruction manual for the human genome that provides a framework to better understand the relationship between an individual’s genetic make-up and their lifestyle.
Monday, March 04, 2013
Yeast Unravels Effects of Chemotherapy Drugs
Researchers identify new biological processes involved in the cellular response to N-BPs, opening up opportunities for the development of new anticancer drugs.
Friday, September 11, 2009
Gene may Hold Key to Future Cancer Hope
The University of Manchester research has identified a key gene that appears to play a critical role in the normal process of cell division.
Tuesday, October 09, 2007
Eden Biodesign and the University of Manchester Intellectual Property Limited Develop Innovative Treatment for Cancer
UMIP selects Eden Biodesign to provide a range of services for the development of therapeutic for treatment of macular degeneration and cancer.
Wednesday, August 08, 2007
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!